Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Non-Current Deferred Tax Liability (2022 - 2025)

Historic Non-Current Deferred Tax Liability for Century Therapeutics (IPSC) over the last 3 years, with Q3 2025 value amounting to $4.4 million.

  • Century Therapeutics' Non-Current Deferred Tax Liability rose 2486.44% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 2486.44%. This contributed to the annual value of $4.4 million for FY2024, which is N/A changed from last year.
  • Per Century Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $4.4 million for Q3 2025, which was up 2486.44% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Non-Current Deferred Tax Liability registered a high of $4.4 million during Q4 2024, and its lowest value of $5000.0 during Q4 2022.
  • For the 3-year period, Century Therapeutics' Non-Current Deferred Tax Liability averaged around $3.5 million, with its median value being $4.4 million (2024).
  • The largest annual percentage gain for Century Therapeutics' Non-Current Deferred Tax Liability in the last 5 years was 2994.65% (2025), contrasted with its biggest fall of 2486.44% (2025).
  • Quarter analysis of 3 years shows Century Therapeutics' Non-Current Deferred Tax Liability stood at $5000.0 in 2022, then soared by 87380.0% to $4.4 million in 2024, then changed by 0.0% to $4.4 million in 2025.
  • Its Non-Current Deferred Tax Liability was $4.4 million in Q3 2025, compared to $4.4 million in Q2 2025 and $4.4 million in Q1 2025.